TWST Q3 2017 Earnings Report — Twist Bioscience Corporation Revenue & Financial Results | Market Cap Arena

Twist Bioscience CorporationTWST

Q3 2017 Earnings

Reported June 29, 2017

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	Q3 2017	Q2 2017	Q3 2016	QoQ Change	YoY Change
Revenue	$3M	—	—	—	—
Op. Income	-$14M	—	—	—	—
Gross Margin	-95.8%	—	—	—	—
Net Margin	-450.8%	—	—	—	—
EPS (Diluted)	$-0.76	—	—	—	—
Free Cash Flow	$0	—	—	—	—

Income Statement

Item	Amount
REVENUE	$3M
Cost of Revenue	$6M
GROSS PROFIT	-$3M
R&D Expenses	$5M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$6M
Other Expenses	$0
Operating Expenses	$11M
Cost & Expenses	$17M
OPERATING INCOME	-$14M
Interest Income	$150.0K
Interest Expense	$0
Other Income/Expenses	-$7.0K
INCOME BEFORE TAX	-$14M
Income Tax Expense	$70.0K
Net Income from Continuing Ops	-$14M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	-$14M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	-$14M
D&A	$1M
EBIT	-$14M
EBITDA	-$13M
EPS	-$1
EPS Diluted	-$1

Cash Flow Statement

Item	Amount
Net Income	-$14M
Depreciation & Amortization	$0
Stock-Based Compensation	$0
Deferred Income Tax	$0
Other Non-Cash Items	$14M
Change in Working Capital	$0
OPERATING CASH FLOW	$0
Capital Expenditure	$0
Acquisitions (Net)	$0
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$0
NET CASH FROM INVESTING	$0
Net Debt Issuance	$0
Common Stock Repurchased	$0
Common Dividends Paid	$0
Other Financing Activities	$0
NET CASH FROM FINANCING	$0
FREE CASH FLOW	$0
Net Change in Cash	$0